Microarray Scanning Articles & Analysis
10 news found
(NYSE: A) today announced that the China Food and Drug Administration has approved the company's SureScan Dx microarray scanner as a medical device for in vitro diagnostic use. "Bringing microarray scanning technology to clinical-quality standards is an important milestone in moving the advancement of genome-wide chromosome analysis to the ...
Agilent Technologies, Inc., (NYSE: A) and Spain's Centre for Omic Sciences announced that they will collaborate on mass spectrometry and NMR-based metabolomics, and automation applied to research in integrated systems biology. The Centre for Omic Sciences, or COS, was established by the Rovira i Virgili University, in collaboration with the Technological Centre of Nutrition and Health. COS ...
Agilent Technologies Inc., (NYSE: A) today introduced SurePrint G3 CGH+SNP cancer catalog microarrays, addressing the growing need of researchers to detect both copy number and copy-neutral aberrations in cancer tissue samples in the same experiment. The new microarray release is accompanied by the release of Agilent CytoGenomics 2.0 software, which now includes support for CGH+SNP analysis of ...
Agilent Technologies Inc. (NYSE: A) today announced that its liquid chromatography/mass spectrometry systems, including 6100 Series single quadrupole and 6400 Series triple quadrupole systems, are now manufactured under ISO 13485 certification. This is an internationally recognized standard of quality management for the design and manufacture of medical devices. "This is just the latest step ...
(NYSE: A) today introduced the SureScan Microarray Scanner, the latest innovation in scanner technology and the foundation of Agilent's complete microarray solution for both gene expression and CGH/cytogenetics research applications. ...
(NYSE: A) today announced that Molecular Genomics is the newest Agilent Certified Service Provider offering microarray services using the Agilent CGH/SNP microarrays, gene expression, and microRNA products. "We are pleased to become an Agilent Certified Service Provider for Microarray Solutions," said Dr. Jeffrey Wee, chief technology officer of ...
Agilent Technologies Inc. (NYSE: A) today introduced Agilent CytoGenomics 1.5 software. This analytical tool gives researchers the ability to streamline their analysis by querying the in-house CytoGenomic database and external databases. The software is designed for easy data interpretation and simple report generation. Agilent provides the most accepted microarray platform for cytogenetics, and ...
NIMGenetics became the first Agilent CSP in Spain after completing training and passing a rigorous series of assessments that included demonstrating proficiency in the complete Agilent integrated microarray workflow: Agilent CGH and CGH/SNP microarrays, sample labeling, hybridization, scanning on the Agilent DNA microarray ...
Agilent Technologies Inc. (NYSE: A) today announced that the United States-Latin American Cancer Research Network (US-LACRN) has selected Agilent Gene Expression microarrays and associated instruments for a major study of breast cancer in five Latin American nations. The researchers will use the microarrays over three years to study gene-expression profiles of 3,000 women with Stage 2 and Stage ...
Untitled Document Showcased Products Focus on New Automation Technology as well as Live Cell Screening, High Throughput Screening Systems and Protein Array Platform PerkinElmer Inc. (NYSE: PKI), a leading provider of drug discovery, life science research, and analytical solutions, today announced the launch of its newest Evolution™ P3 now with ...